Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
san francisco top stories
10
×
biotech
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
national
raleigh-durham blog main
raleigh-durham top stories
cancer
clinical trials
detroit blog main
detroit top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
fda
indiana blog main
indiana top stories
deals
ipo
pfizer
cancer immunotherapy
investing
medical devices
merck
renaissance capital
startups
biotech ipos
What
life
10
×
science
companies
ipo
week
bio
roundup
biotechs
firms
new
public
street
wall
biotech
company
haul
ipos
millions
momentum
moves
raised
sciences
therapeutics
way
welcomed
admits
ago
arena’s
arrival
bails
becker
big
billions
black
blood
boost
bounty
brand
bridgebio
broader
Language
unset
Current search:
xconomy.com
×
life
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M